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The myosin light chain complement and proteolytic peptide patterns of myosin heavy chains were studied by two-
dimensional and one-dimensional electrophoretic techniques respectively, in a total of 57 samples from
ventricular and atrial tissues of normal and hypertrophied human hearts. Hypertrophies were classified
haemodynamically as due to pressure-overload and volume-overload. In addition to the occurrence of ventricular
light chains in hypertrophied atria we also observed the atrial light chain-1 (ALC-1) in hypertrophied
ventricular tissues. On average over 6% of total light-chain-1 comprised ALC-1 in pressure-overloaded ventricles
and around 3% in volume-overloaded ventricles. In single cases of pressure-overload ALC-1 amounted up to over
20% of total light chain-1. With regard to the myosin heavy chains limited digestion by two different proteinases
produced over 200 clearly resoluble peptides. The absence of any detectable differences in the peptide patterns
between myosin heavy chains from normal and hypertrophic tissues of left or right ventricle is in line with the
findings of J. J. Schier and R. S. Adelstein (J Clin Invest 1982; 69: 816-825). In atrial tissues however,
reproducible qualitative differences in the peptide patterns indicated that during hypertrophy a different type of
myosin heavy chains becomes expressed. No differences were seen between the myosin heavy chains from normal
left and right atria.
Introduction myosin has the highest and V3 the lowest
ATPase activity'9'10'.
In cardiac muscle the contractile protein myosin is Based on comparison of electrophoretic mobilities
dimeric and consists of two heavy chains (HC) with in normal human ventricle the main isoenzyme is
an approximate molecular weight of 200000 dalton thought to be V3 with its low ATPase activity'611',
and 4 light chains (LC), a couple of each with a The enzymatic centre is known to be comprised
molecular weight of around 21000 and 18000 within the HC only and the LC seem not to affect
dalton'11. The existence of myosin isoenzymes in the ATPase of isolated myosin"2 '13 '. Thus shifts in
cardiac muscle has been postulated to explain the the composition of the HC isoforms are expected to
correlation between myosin ATPase activity as be accompanied by changes in ATPase activities,
measured in vitro and altered myocardial contractile However, a decline in myofibrillar ATPase activity
properties in disease states'2-3'. Furthermore, shifts has been reported for human ventricles in congestive
in myosin isoenzyme composition with regard to heart failure'14 'and severe hypertrophic states"5 '16 ',
both HC and LC, have also been observed during No change in myosin or myofibrillar ATPase
ontogenetic development of the heart of man and activities nor in the structure of the myosin HC as
animals'4"7 '. In heart ventricles of rodents two types judged from their peptide pattern, has been observed
of myosin HC have been described which are able to in ventricles of patients with hypertrophic
form homodimeric and heterodimeric isoenzymes obstructive cardiomyopathy'17-18'. So in this latter
designated in order of decreasing electrophoretic disease there seems to occur no transition in the
mobility as Vj = 2 x HC-alpha, V2 = HC- expression of the isoforms of HC. The lower
alpha + HC-beta and V3 = 2 x HC-beta(8'. Vi myofibrillar ATPase activities observed in hyper-
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trophies induced by pressure- or volume-overload is
difficult to explain on the grounds of changes in the
composition of HC isoforms, since the normal heart
ventricle already contains almost exclusively V3
myosin with the lowest ATPase activity. Either a
new additional type of myosin HC may become
expressed in some forms of heart diseases or else the
LC complement, if its composition changes, might
still affect the enzymatic properties of the intact
myofibril. Recently it has been reported for skeletal
muscle myosin that the LC indeed play a role in the
subtle interaction of the myosin head portions where
the LC are located, with their reaction partner actin
and the calcium-sensitive regulatory proteins
troponin and tropomyosin(19). Therefore
examination of both HC and LC is required.
Transition in the LC complement both in human
atria and ventricles have been reported recently to
occur in response to cardiac pressure overload'20'211.
Thereby LC characteristic for ventricle appear in the
atrium under pathologic conditions and vice versa.
The atrial LC, (ALC,) which occurs in the ventricle
of pathologically hypertrophied hearts can also be
observed in man and animals to be present in early
developmental stages in the foetal ventricle and to
disappear after birth'5-22'23'. Apparently both heart
chambers have retained the ability of transition of
their LC complement in the adult. We have therefore
undertaken a structural study of both LC and HC in
ventricles and atria of normal and pathologically
hypertrophied human hearts. It was possible to
quantify the occurrence of the atrial ALC, in
hypertrophic ventricles in response to pressure- and
volume-overload separately. In the right ventricle of
children fewer ALC, emerged in hypertrophy due to
pressure-overload. But in an infant at the age of 7
months a large portion of ALC,, which is present
normally in the foetal ventricle, was retained in the
hypertrophic right ventricle. In contrast, no
structural transition was apparent in the myosin HC
from hypertrophic ventricles, but we report here for
the first time a change in the peptide pattern of HC
in pathologically hypertrophic atria.
Methods
Left ventricular endomyocardial biopsy material
was obtained from 15 patients by the transseptal
route, whereby the King's College Bioptome was
advanced through a French-11-5-Brockenbrough
catheter from the right femoral vein to the left
ventricle. The samples were derived mainly from the
lateral apical portion of the left ventricle. Samples
from pathological and normal ventricular or atrial
tissues were taken during surgery or from autoptic
material within 8 h after death. Cases with left
ventricular hypertrophy were classified on haemo-
dynamic grounds as due to pressure-overload with
maximal and average pressure gradients above
30 mmHg and valve opening areas below 1-5 cm2, or
as due to volume-overload with regurgitation
fractions above 40%.
Tissue fragments were stored at — 20°C or below
until usage. Samples of 1-10 mg were homogenized
in the appropriate buffer system and directly applied
to electrophoresis. Protein concentrations were
determined according to Lowry and coworkers(24).
One-dimensional polyacrylamide gel electrophoresis
in the presence of sodium dodecyl sulphate (SDS)
was carried out according to Laemmli and Favre(25)
by using 3% stacking (3x18 cm) and 12-5%
separating gels (13 x 18 cm) of 1-5 mm thickness and
applying around 25 pig protein per sample. For two-
dimensional gel electrophoresis isoelectric focusing
was beforehand carried out in the first dimension
according to O'Farrell'26' by using a (4:1, v/v)
mixture of ampholines (1-75%) of the pH range 5-8
and 3-5—10 respectively. Polyacrylamide gels (3-64%)
of 11 -5 cm length were prepared in glass tubes (3 mm
inner diameter and 17 cm long). For isoelectro-
focusing around \20 fig of each sample were applied
to the top of the pre-electrophoresed gels. The
protein in all different gels were visualized by
staining in 0-25% Coomassie Brillant Blue R-250.
Destaining of gels and determination of pH gradient
in isoelectric focusing gels were done as before'27'.
For isolation of myosin HC, tissue samples were
homogenized in 10 vol of 40 mM sodium pyro-
phosphate (pH 7-5 adjusted with HC1) containing
2 mM dithiothreitol and 5 mM ethylene-glycol-bis
(beta-amino ethylether) N,N-tetraacetic acid1281.
Immediately before electrophoresis, 4 mM N-ethyl-
maleimide were added to the sample containing
between 200 and 400 ng of protein, which were
loaded on gels composed of 3% acrylamide and
0-24% bis-acrylylcystamine'29). Chamber and gel
buffer, pH 8-4, were composed of tris-(hydroxy-
methyl)aminomethanol (Tris) and (N,N-bis(2-
hydroxyethyl)glycine) (Bicine) containing 0-1 % SDS
as described elsewhere'30'. After the electrophoretic
run, gels were stained with Coomassie Brillant Blue
R-250, subsequently soaked for 15 min in 20%
methanol followed by 15 min in the chamber buffer
Tris-Bicine pH 8-4. Then bands representing myosin
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HC were excised and the gel slices dissolved by
addition of 3-4% beta-mercaptoethanol. To these
samples were added 0-5 vol. bringing the final
concentrations similar to those described by Whalen
and coworkers(31): 70 mM Tris, 70 mM Bicine,
0-23% SDS, 3-5% beta-mercaptoethanol, 150 mM
NaCl, 003 mM MgCl2, 48 mM phosphate buffer pH
6-5. For digestion of 80-100 ng of myosin HC per
sample, proteinase from Staphylococcus aureus V8
(EC 3.4.21.19) (Miles, Elkhart, Indiana, USA) and
papain (EC 3.4.22.2) (Boehringer, Mannheim, West
Germany) were used. The molar ratio of both
proteinases to myosin HC of 200000 dalton
molecular weight range from 0-001 up to 005 based
on the molecular weights of 27 700 dalton for the
proteinase V8 and 23 350 dalton for proteinase
papain. Digestion was performed for 30 min at 37°C
and the reaction stopped by addition of around 100-
fold molar excess of phenylmethylsulphonyl fluoride
in the case of the proteinase V8 and by heating
samples for 3 min at 100°C in the case of proteinase
papain. The protein digest was then resolved on
usual one-dimensional gel electrophoresis in SDS(25).
All peptide patterns were stained by Coomassie
Brillant Blue R-250, and in many cases they were,
after destaining in 40% methanol plus 10% acetic
acid, stained again with silver'32' in order to increase
sensitivity for visualization of peptides occurring in
small quantities.
One-dimensional stained gels and positive films of
them were scanned and recorded either by the
Gilford Spectrophotometer System 2600 (Gilford
Instr. Lab. Inc., Oberlin, Ohio, USA) at 560 nm or
by the LKB 2202 UltroScan Laser Densitometer
(LKB-Produkter AG, Bromma, Sweden) at 633 nm.
In two-dimensional electrophoresis, firstly, the
central absorbance of the spots on the stained gels
and on their films was measured with the McBeth
TD 504 Densitometer (McBeth Color & Photo-
metry Div., Newburgh, New York, USA). Secondly,
the spots were excised from enlarged prints and
weighed. With purified tropomyosin for calibration
the average of the two measurements yielded a
relationship that was linear from 0-5 up to 14 t^g of
protein per spot. In this way the myosin LC were
quantified in each two-dimensional gel relative to
tropomyosin. No allowance was made for possible
differences in dye-uptake by these proteins. For
calculation of the stoichiometry the chemical
molecular weights of 21 000 dalton for LC,, 18000
for LC2 and 66 000 for tropomyosin from both atrial
and ventricular tissues were taken. This needs to be
mentioned for the apparent molecular weights of the
LC in SDS gel electrophoresis are different: 27400
dalton for LC, and 22600 for LC2 from atrium and
26000 dalton for LC, and 21000 for LC2 from
ventricle'22'. The myosin HC and sometimes also
actin were not reliably resolved in the isoelectro-
focusing run and could therefore not be quantified.
Results
VARIATION IN LIGHT CHAIN COMPLEMENT
In support of the finding of Cummins'20' we also
observed the occurrence of additional myosin LC in
hypertrophied atria which exhibit identical electro-
phoretic mobilities to those of the ventricle VLC,
and VLC2. Such a ventricular VLC2 was
consistently found in atrial tissues from severely
hypertrophic hearts. It mostly appeared as double
spot due to partial phosphorylation. But
occasionally a faint, more acidic, third spot was also
visible which is thought to represent a second type of
VLC2(2O). Such a second VLC2 type has also been
described in several vertebrate species beside man'33'.
The VLC, type occurring in hypertrophic atria was
variable and in all cases much reduced in
comparison to its VLC2 counterpart. Quantification
was therefore not attempted. Quantification of the
VLC2 occurring in atria neither proved to be useful
since the total amount of the LC2 type varied in
both atrial and ventricular tissues of normal as well
as hypertrophic hearts. Thereby the LC2 type
displayed the tendency to be reduced variably in
comparison to the LC, type.
On the other hand, the LC, type exhibited a
remarkable constancy in amount related to that of
tropomyosin (Table 1). Fig. 1 shows the occurrence
Table I Occurrence of atrial ALCX in hypertrophic and
normal left ventricles. Total LCS content is given as molar
ratio to tropomyosin and ALCX as percentage thereof. The
occurrence of ALCl is significant in both forms of
hypertrophy at the level of P<00l in comparison to normal
ventricles (mean values are given)
Age in Number Total LC,
Condition years of cases per tropomyosin %ALC,
Normal
Pressure-
overload
Volume-
overload
23-66
35-79
32-72
7
15
10
2-7
3-4
2-5
0-4
6-3
2-8
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VLC1
VLC2
Figure I Two-dimensional electrophoresis of total tissue homogenate from left
ventricles. Gels are presented with the basic pH range in isoelectrofocusing (IEF) to the
left and decreasing molecular weights from top to bottom in SDS electrophoresis. Left
side, normal ventricle of a women at the age of 41 years. Right side, ventricle of a man at
the age of 39 years with pressure-overload. TM, mainly alpha-tropomyosin with some little
beta-tropomyosin on top; VLC, and VLC2, ventricular myosin LC; arrow indicates the
ALC, in the hypertrophic ventricle.
of ALC, in the left hypertrophic ventricle of an
adult in comparison to a normal case.
Quantification of the atrial ALC, occurring in
hypertrophic ventricles under pathological
conditions seemed useful and led to the results given
in Table 1. The total amount of LC, type is expressed
in moles of LC, per mole of tropomyosin with a
molecular weight of 66 000 dalton as described in the
methods section. The content of the total amount of
LC, did on average not vary significantly between
normal and hypertrophic ventricular tissues. There
was a slight tendency of higher values of total LC,
in some cases of severe pressure-overload, reaching
extremes of 40 and 9-6 in two single instances. In
these latter cases however, the portion of ALC, did
not exceed 5 and 6%, respectively. On the other
hand, the additional ALC, was significantly
increased in hypertrophic (/><0-0l) when compared
with normal tissue. In pressure-overload the portion
of ALC, varies between 1 and 27% of total LC,
whereas in volume-overload it ranged between 1 and
5% only. In normal ventricular tissue ALC, was
seen occasionally as a very faint spot which never
exceeded 0-5% of total LC,.
In four children at the age of 2-7 years with
pressure-overload of the right ventricle due to
congenital malformation (tetralogy or trilogy of
Fallot), the portion of ALC, in the ventricular tissue
ranged between 0-5 and 2-7%. In an infant at the age
of 7 months the portion of ALC, in the ventricle
attained 29%. At this age in normal infants the
relative content of ALC, in the ventricle is around
1-5% and decreases continuously until, at the age
of around one year, it has disappeared completely.
Price and coworkers(5) have reported a value of
5-7% for the portion of ALC, in the normal
ventricle of an infant at the age of 8 months.
In two cases with pressure-overload samples were
taken separately from both subendocardial and
subepicardial muscle layers, in one case of the left
ventricle from an adult and in the other from the
right ventricle of a child. In both cases the inner and
outer muscle layers displayed almost identical LC
patterns. In particular, the ventricular ALC, did not
vary significantly between the two layers. Further-
more, in co-electrophoresis of the two muscle layers
of one heart, but also in co-electrophoresis of the
hearts of the two patients, the ventricular ALC,
always appeared as one single co-migrating spot.
VARIATION IN HEAVY CHAIN STRUCTURE
Limited digestion of isolated myosin HC either
with proteinase V8 or with proteinase papain were
performed in the presence of 0-23% SDS under
carefully controlled conditions. Examined were 5
cases of left ventricles and 3 cases of left atria from
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Figure 2 Densitometric traces of electrophoretograms with peptide patterns
of myosin HC from normal left atrial and ventricular tissues after digestion
with proteinase V8 (ratio to myosin HC, 005). Coomassie staining. V,
ventricle; A, atrium; arrows indicate qualitative differences (see text in results
section).
pressure-overloaded hearts of adults, 2 cases of right
ventricles from pressure-overloaded hearts of
children, 3 cases of normal left ventricles, 4 cases of
normal left atria and 2 cases of normal right atria. In
each digestion experiment one or two pathological
samples were processed at a time strictly in parallel
with a normal one. In separate experiments two
normal samples or, alternatively, two or three
pathological samples were processed together. Each
experiment consisted of a series of parallel digestions
with varying concentrations of the proteinases in
relation to the concentration of the myosin HC as
indicated in the methods section. Peptide patterns
were thus obtained in one-dimensional electro-
phoretic resolution with both proteinases, in which
the majority of peptide bands spread predominantly
over the high (80-200 kdalton), middle (30-120
kdalton) or low (10-50 kdalton) molecular weight
ranges. In this way well over 200 peptide bands
could clearly be distinguished per sample and
compared with those of the experimental
companions.
Densitometric evaluation was only justified when
the patterns to be compared indicated equal degrees
of digestion that is the staining intensity of most
peptide bands was very similar. As soon as there
were different amounts of undigested material
between the parallels left at the top of the gel slab, or
if in some regions variable staining intensities
indicated unequal digestion between them, such
experiments were rejected. Particular caution had to
be exerted if differences appeared among the protein
bands in the high molecular weight range of samples
which were processed in parallel. Repetitive experi-
ments proved that in this region transiently
occurring peptide bands were occasionally seen in
single digestions which could not be reproduced.
However, in the middle and low molecular weight
ranges differences or, alternatively, no differences at
all, between parallels, were clearly recognizable and
also reproducible. No differences at all could be
detected with either proteinase between the peptide
patterns of myosin HC from right or left ventricles
nor between those originating in the outer, middle or
inner muscle layers of the left ventricular wall or in
the papillary muscles.
The peptide patterns of myosin HC from atrium
and ventricle of a normal adult heart in Fig. 2 show
a large number of differences in the low molecular
weight range after digestion with proteinase V8. The
differences pointed out in Fig. 2 concern peptide
bands which occur in one of the two digestion
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Figure 3 Densitometric traces of electrophoretograms
with peptide patterns of myosin HC from normal and
hypertrophic left ventricles after digestion with papain
(ratio to myosin HC, 002). Coomassie staining. V, normal
ventricle of a man at the age of 29 years; VH, ventricle of a
man at the age of 79 years with pressure-overload.
patterns only and do not reflect merely quantitative
differences of bands existing in both patterns. Fig. 3
comprises peptide patterns of myosin HC after
digestion with papain from normal and hyper-
trophied left ventricles of adults. The two patterns
are almost identical. On close inspection only minute
quantitative variation in some of the smallest peptide
bands can be detected. In no parallel digestion of
myosin HC from normal and hypertrophic ventricles
did we ever see reproducible qualitative differences.
This confirms the results of Schier and Adelstein(I8)
who did neither find differences in the peptide
patterns of ventricular myosin from normal and
hypertrophic cardiomyopathic hearts. In their case
intact native myosin was digested with alpha-
chymotrypsin and papain.
In contrast, qualitative differences could be
detected between the peptide patterns of myosin HC
from normal and hypertrophic atrial tissues. The
samples shown in Fig. 4 both stem from left atria
and were digested with papain. Beside the qualitative
differences pointed out by the arrows numbered 1-3,
much larger qualitative variations in single bands
can be seen than in the two patterns from ventricular
myosin HC in Fig. 3. Such a quantitative variation
of a particular band is marked with the arrow
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Figure 4 Densitometric traces of electrophoretograms
with peptide patterns of myosin HC from normal and
hypertrophic left atria after digestion with papain (ratio to
myosin HC, 005). Silver staining. A, normal atrium of a
woman at the age of 41 years; AH, atrium of a woman of
the age of 55 years with pressure-overload; arrows 1—3
indicate qualitative differences; arrow 4 points to a
quantitative difference (see text in results section).
number 4, but immediately to the higher molecular
weight side of arrow number 1 is a triplet of bands
exhibiting also considerable quantitative variation
between the two patterns. Thus unlike the myosin
HC from ventricle, those from atrium do become
changed in hypertrophy. Of the 3 hypertrophic left
atria examined, two displayed identical peptide
patterns between themselves while the third one
differed. The patterns of all normal atrial tissues
looked identical, even those from right and left atria.
Discussion
The present study indicates that transitions in the
myosin LC complement occur in both atria and
ventricles with pathological hypertrophies. In left
atria an additional VLC2 is found predominantly
while in the ventricles an ALC, shows up. Thus in
the former case we observed a partial transition of
LC in an atrial-ventricular, and in the latter, in
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contrast, in a ventricular-atrial direction. This is
somewhat unexpected. It has been speculated the
primitive cardiac tube may synthesize mainly an
atrial-related type of myosin(5). Under the stimulus
of increasing pressure and workload experienced by
the newly developing ventricular chamber, ventricular
myosin will then come to be produced. In the atrium
this sequence of events seems to be maintained when
under pathological work-overload ventricular LC
become expressed. In the ventricle however, despite
an even greater workload, the genetic expression
switches back to the primordial type of atrial-like
LC. It appears then that with regard to the LC
complement which seems to undergo opposing
transitions, the isoenzyme expression follows some
pre-determined pattern rather than to obey the
functional stimulus.
As expounded in the results section quantification
of the LC, type alone led to sensible results. The
LC2 type varied in both atria and ventricles in an
unpredictable way. It has been reported that this
LC2 type characteristic of myosins with low ATPase
activity, always yields variable recoveries by various
extraction procedures'30'. The appearance of ALC,
is highly significant for a pathologically increased
workload of the left ventricle. Its appearance is
further more pronounced under pressure-overload
than under volume-overload. The relatively low level
of ALC, compared to the normal VLC, content
may explain why Klotz and coworkers'34' failed to
detect variations in the primary structure of the LC
in human hypertrophied left ventricles. In children
with pressure-overload of the right ventricle the
ventricular-atrial transition of the LC, type remains
even more moderate. However, within the first year
of age, where some little ALC, is still being
produced under normal conditions, under pressure-
overload the amount of ALC, in the right ventricle
is very large indeed. At this young age the large
proportion of the atrial ALC, in the right ventricle
affected by congenital malformation reflects the
persistence of its otherwise declining normal
expression.
The total content of the LC, type in ventricular
tissue amounts on average to around 3 moles per
mole of tropomyosin. This latter was found to be the
most reliable reference protein. In sarcomeric
muscles the molar ratio of myosin to tropomyosin
was determined to be very close to unity<35). Isolated
ventricular myosin contains two moles of LC, and
LC2 each per mole'36'. Thus two moles of LC, type
would be expected per mole of tropomyosin.
In total ventricular tissue homogenates we found a
constant amount of LC, type just below three moles
per mole of tropomyosin (Table 1), which is very
close to the expected value. If the ratio of myosin to
tropomyosin is indeed one, then almost all LC, seem
to be bound to myosin. The myosin LC are known
to have in heart muscle a somewhat slower turnover
rate than the HC'37', so there might be a small
surplus in the pool of LC in the tissue in order to
allow all myosin HC to combine with the
appropriate LC to form intact molecules. We
observed a tendency of total LC, type to increase in
ventricles with hypertrophy due to pressure-
overload. The quantitative analyses of the individual
cases indicate however, that this increase in total
LC, type was never caused specifically by the
additional ALC, in the ventricle. It rather results
from a general stimulation of synthesis of the LC,
type. Should the content of total LCt be related to
that of HC, then myosin would on average not vary
drastically in hypertrophic ventricles.
Our new finding with regard to the myosin HC
concerns the occurrence of a HC isoform in
hypertrophied left atria from patients with pressure-
overload. In normal hearts the HC structure as
revealed in the peptide patterns was identical in right
and left atria. Ventricular myosin HC are different
from normal and pathological atrial myosin HC. In
ventricles we never found a difference between normal
and hypertrophied tissues. Under the stringent
criteria laid down in the results section this means
that in the absence of qualitative differences the
primary structures of the HC from normal and
pathological ventricles have an extremely high
degree of homology or they may indeed be identical.
The presence of a new HC species in hypertrophy in
appreciable amounts is excluded by our findings,
since a single additional peptide band from such a
new species amounting to, or exceeding, 5% of total
protein would not be overlooked in electrophoresis.
The peptide patterns of HC from ventricles could in
principle result from a mixture of HC isoforms. But
again such a mixture would have to remain constant
in proportion in normal and pathological ventricles
since we did not even find significant quantitative
differences between them. Electrophoresis of intact
native myosin and immunochemical tests have
shown that normal human ventricle in fact
comprises mainly one isoenzyme, the V3
myosin'6'1".
On the other hand, the qualitative differences in
the peptide patterns of HC from normal and
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pathological atria indicate the occurrence of a new
isoform in hypertrophy which is not present in the
normal right or left atria. In atrium again a mixture
of more than one HC isoform could be present
normally, and the additional quantitative differences
under pathological conditions would then indicate
furthermore, a shift in the composition of the basic
isoenzyme pattern. Or else, if the normal atrium
contains only one HC isoform the quantitative
changes may simply reflect its relative decline as the
new species arises in hypertrophy.
Alpert and coworkers(38) have demonstrated that
hypertrophying heart tissue adapts to slow,
economical tension development in response to
pressure-overload. In small rodents this is
accompanied by a transition of isoenzymes from the
normally present V! myosin with high ATPase
activity to V3 with low activity'9'. In man(6>11) as
well as in larger animals V3 represents the main
isoenzyme in normal ventricles'6-20' and as shown
here for man, no transition in HC isoforms occurs
under pathological workload. In atria however,
whose myosin has a higher ATPase activity than its
ventricular counterpart'39', adaptation to the
increased workload by expression of a new isoform of
HC is still possible. Presumably this new myosin
isoenzyme has a lower ATPase activity, though this
remains to be proven.
In conclusion, we have shown that the expression
of isoforms of myosin HC seems to follow functional
adaptation in human atria under increased workload
while no such isoenzymatic transition takes place in
ventricles. On the other hand, the LC complement is
regulated independently of the HC and changes in
hypertrophied atria towards the ventricular, and in
hypertrophied ventricles towards the atrial
composition. Presently we are examining the LC
transitions in various forms of heart disease and it
seems that some diagnostic value could be derived
from the knowledge of the LC pattern.
We are particularly indebted to Professor M. Turina,
Department of Surgery, University Hospital, Zurich, for 23
heart samples taken during surgery and to Dr J. Schneider,
Department of Pathology, University Hospital, Zurich, for
19 heart samples from autopsy. This work was supported
by the Swiss National Science Foundation grant 3.535.79
and 3.152.81, the Swiss Foundation of Cardiology and the
Fritz Hoffmann-LaRoche Foundation.
References
(!) Weeds AG, Frank G. Structural studies on the light
chains of myosin. Cold Spring Harbor Symp Quant
Biol 1972; 37: 9-14.
(2) Scheur J, Bhan AK.. Cardiac contractile proteins:
activity and physiological function. Circ Res 1979; 45:
1-12.
(3) Jacob R, Rupp H, Ebrecht G, Holubarsch C, Kissling
G. The significance of the isoenzyme pattern of myosin
for myocardial mechanics and energetics. Relevance to
the definition of cardiac contractility. Z Kardiol 1982;
71: 553-65.
(4) Whalen RG, Sell SM. Myosin from fetal hearts
contains the skeletal muscle embryonic light chain.
Nature 1980; 286: 731-3.
(5) Price KM, Littler A, Cummins P. Human atrial and
ventricular light-chain subunits in the adult and during
development. Biochem J 1980; 191: 571-80.
(6) Lompre AM, Mercadier JJ, Wisnewsky C. et al.
Species- and age-dependent changes in the relative
amounts of cardiac myosin isoenzymes in mammals.
Develop Biol 1981; 84: 286-90.
(7) Chizzonite RA, Everett AW, Clark WA, Jakovcic S,
Rabinowitz M, Zak R. Isolation and characterization
of two molecular variants of myosin heavy chain from
rabbit ventricle. Change in their content during normal
growth and after treatment with thyroid hormone. J. Biol
Chem 1982; 257: 2056-65.
(8) Hoh JFY, Yeoh GPS, Thomas MAW, Higginbottom
L. Structural differences in the heavy chains of rat
ventricular myosin isoenzymes. FEBS Letters 1979; 97:
330-4.
(9) Hoh JFY, McGrath PA, Hale PT. Electrophoretic
analysis of multiple forms of rat cardiac myosin.
Effects of hypophysectomy and thyroxine replacement.
J Molec Cell Cardiol 1978; 10: 1053-76.
(10) Pope B, Hoh JFY, Weeds A. The ATPase activities of
rat cardiac myosin isoenzymes. FEBS Letters 1980;
118:202-8.
(11) Clark WA, Chizzonite RA, Everett AW, Rabinowitz
M, Zak R. Species correlations between cardiac
isomyosins. A comparison of electrophoretic and
immunological properties. J Biol Chem 1982; 257:
5449-54.
(12) Wagner PD, Giniger E. Hydrolysis of ATP and
reversible binding to F-actin by myosin heavy chains
free of all light chains. Nature 1981; 292: 560-2.
(13) Wagner PD, Weeds AG. Studies on the role of myosin
alkali light chains. Recombination and hybridisation
of light chains and heavy chains in subfragment-1
preparation. J Mol Biol 1977; 109: 455-73.
(14) Alpert NR, Gordon MS. Myofibrillar adenosine
triphosphatase activity in congestive heart failure. Am
J Physiol 1962; 202: 940-6.
(15) Leclerq JF, Swinghedauw B. Myofibrillar ATPase,
DNA and hydroxyproline content of human hyper-
trophic heart. Eur J Clin Invest 1976; 6: 27-33.
(16) Swinghedauw B, Schwartz K, Leger JJ. Cardiac
myosin. Phylogenic and pathologic changes. Basic Res
Cardiol 1977; 72: 254-60.
(17) Maron BJ, Ferrans VJ, Adelstein RS. Isolation and
characterization of myosin from subjects with
Myosin isoenzymes 93
asymmetric septal hypertrophy. Circ Res 1977; 40:
468-73.
(18) Schier JJ, Adelstein RS. Structural and enzymatic
comparison of human cardiac muscle myosins isolated
from infants, adults and patients with hypertrophic
cardiomyopathy. J Clin Invest 1982; 69: 816-25.
(19) Wagner PD, Stone DB. Calcium-sensitive binding of
heavy meromyosin to regulated actin requires light
chain-2 and the head-tail junction. Biochemistry 1983;
22: 1334-42.
(20) Cummins P. Transitions in human atrial and
ventricular myosin light-chain isoenzymes in response
to cardiac-pressure-overload-induced hypertrophy.
Biochem J 1982; 205: 195-204.
(21) Tuchschmid CR, Srihari T, Hirzel HO, Schaub MC.
Structural variants of heavy and light chains of atrial
and ventricular myosins in hypertrophied human
hearts. In: Cardiac adaptation to hemodynamic
overload, training and stress. Steinkopff-Verlag, 1983:
123-8.
(22) Srihari T, Tuchschmid CR, Hirzel HO, Schaub MC.
Electrophoretic analyses of atrial and ventricular
cardiac myosins from foetal and adult rabbits. Comp
Biochem Physiol 1982; 72B: 353-7.
(23) Srihari T, Tuchschmid CR, Schaub MC. Isoforms of
heavy and light chains of cardiac myosins from rat and
rabbit. Basic Res Cardiol 1982; 77: 599-609.
(24) Lowry OH, Rosebrough NJ, Farr AL, Randall RF.
Protein measurement with the Folin phenol reagent. J
Biol Chem 1951: 193: 265-75.
(25) Laemmli UK, Favre M. Maturation of the Head of
bacteriophage T4. I. DNA packaging events. J Mol
Biol 1973; 80: 575-99.
(26) O'Farrell PH. High resolution two-dimensional electro-
phoresis of proteins. J Biol Chem 1975; 250: 4007-21.
(27) Srihari T, Wiehrer W, Pette D, Harris BG. Electro-
phoretic analysis of myofibrillar proteins from the
body wall muscle of Ascaris suum. Mol Biochem
Parasitol 1981; 3: 71-82.
(28) Rupp H. The adaptive changes in the isoenzyme
pattern of myosin from hypertrophied rat myocardium
as a result of pressure overload and physical training.
Basic Res Cardiol 1981; 76: 79-88.
(29) Hansen JN. Electrophoresis of ribonucleic acid on a
polyacrylamide gel which contains disulfide-
crosslinkages. Anal Biochem 1976; 76: 37-44.
(30) Weeds AG. Light chains from slow-twitch muscle
myosin. Eur J Biochem 1976; 66: 157-73.
(31) Whalen RG, Schwartz K, Bouveret P, Sell SM, Gros
F. Contractile protein isozymes in muscle
development; identification of an embryonic form of
myosin heavy chain. Proc Nat Acad Sci USA 1979; 76:
5197-201.
(32) Wray W, Boulikas T, Wray VP, Hancock R. Silver
staining of proteins in polyacrylamide gels. Analyt
Biochem 1981; 118: 197-203.
(33) Westwood SA, Perry SV. Two forms of the P-light
chain of myosin in rabbit and bovine hearts. FEBS
Letters 1982; 142: 31-4.
(34) Klotz C, Leger JJ, Elzinga M. Comparative sequence
of myosin light chains from normal and hypertrophied
human hearts. Circ Res 1982; 50: 201-9.
(35) Potter JD. The content of troponin, tropomyosin,
actin and myosin in rabbit skeletal muscle myofibrils.
Arch Biochem Biophys 1974; 162: 436-41.
(36) Pfister M, Schaub MC, Watterson JG, Knecht M,
Waser PG. Radioactive labeling and location of
specific thiol groups in myosin from fast, slow and
cardiac muscles. Biochim Biophys Acta 1975; 410:
193-209.
(37) Zak R. Metabolism of myofibrillar proteins in the
normal and hypertrophic heart. Basic Res Cardiol
1977; 72: 235-40.
(38) Alpert NR, Mulieri LA, Litten RC. Functional
significance of altered myosin adenosine triphosphatase
activity in enlarged hearts. Am J Cardiol 1979; 44:
947-53.
(39) Yazaki Y, Ueda S, Nagai R, Shimada K. Cardiac
atrial myosin adenosine triphosphatase of animals and
humans. Circ Res 1979; 45: 522-7.
